ACRC_RGB

Alberta is a hotbed of research activity. Click here for a “by the numbers” look at clinical research activities across the province generated though submissions provided by ACRC partner organizations.

 

Disclaimer: The information provided below is intended to be general summary information for the public. It is not ACRC’s intention to provide specific medical advice or recommendations to users of this website. ACRC urges users to consult with a qualified health care professional for diagnosis and answers to their personal medical questions.

 

Studies Open for Recruitment in Alberta:

The following clinical trials have recently opened for participant recruitment as collated from clinicaltrials.gov (between February 1, 2016 – August 31, 2016). The list includes trials with Alberta-based sites that are actively recruiting* or are soon to be recruiting. Check with the study team for the latest study status. If you have an open study you wish to include, please email acrc@albertainnovates.ca

Interventional, randomised, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study of vortioxetine in paediatric patients aged 7 to 11 years, with Major depressive disorder (MDD)
Interventional, randomised, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study ofvortioxetine in paediatric patients aged 12 to 17 years, with Major depressive disorder (MDD)
International Nutrition Audit in FORegut TuMors
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation, a Multicenter Study
A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma
BI 655066 Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Subjects With Newly Diagnosed Multiple Myeloma
BI 655066 Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
MEDi Robot for Pain Management at Induction
ADT Exercise Trial and Economic Analysis
The Fontan Education Study: A Randomized Control Trial
Omental Islet Transplant
More-2-Eat; Implementation of INPAC
Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease
STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Protein Recommendation to Increase Muscle
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)
Impact of Stress on Performance of Neonatal Endotracheal Intubation
A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung Cancer
A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers and Patients With Ulcerative Colitis
Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal or Gastroesophageal Junction Cancer
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study
Effect of High Altitude Exposure, Acclimatization and Re-exposure on Sustained Attention in Lowlanders
Study of BMS-986178 Monotherapy or in Combination With Nivolumab or Ipilimumab in Subjects With Advanced Solid Tumors
Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance in Lowlanders
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer
Study of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Multiple Myeloma
Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer
Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
Microarray Prediction of Response to Nivolumab, Ipilimumab, or Combined Therapy in Subjects With Previously Untreated, Locally Advanced or Metastatic Melanoma
An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than 6 to Less Than 12 Years of Age
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS)
An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada
Randomized Trial Comparing Colesevelam vs. Ezetimibe
Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Share on LinkedIn